Health and Fitness Health and Fitness
Tue, January 31, 2012
[ Tue, Jan 31st 2012 ] - Market Wire
Patient Home Monitoring (PHM) Announces Audited F .. cal Quarter 2012 Results and Anticoagulation Clin
[ Tue, Jan 31st 2012 ] - Market Wire
Dendreon, Delta Air Lines, JDS Uniphase
[ Tue, Jan 31st 2012 ] - Market Wire
Catasys Contracts With Coventry Health Care of Oklahoma
[ Tue, Jan 31st 2012 ] - Market Wire
Community Health Systems Announces Execution of A .. ate with Longview, Texas, Multi-Speciality Clinic
[ Tue, Jan 31st 2012 ] - Market Wire
Health Netas & UCLAas Health Literacy Social Media Program Opens to All Teens Nationwide
[ Tue, Jan 31st 2012 ] - Market Wire
Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies
[ Tue, Jan 31st 2012 ] - Market Wire
Biotech Sector on the Upswing -- Dendreon and ADVENTRX Pharmaceuticals Looking Strong
[ Tue, Jan 31st 2012 ] - Market Wire
Biomerica Launches New Patented Test to Identify .. eloping Severe Side Effects From Thiopurine Drugs
[ Tue, Jan 31st 2012 ] - Market Wire
West to Present at UBS Conference
[ Tue, Jan 31st 2012 ] - Market Wire
AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012
[ Tue, Jan 31st 2012 ] - Market Wire
Life Technologies Names Alan Sachs as Head of Global Research and Development
[ Tue, Jan 31st 2012 ] - Market Wire
Biogen Idec nombra a Kenneth DiPietro Vicepresidente ejecutivo de Recursos Humanos
[ Tue, Jan 31st 2012 ] - Market Wire
Reflect Scientific, Inc. Has Positive Outlook for 2012
[ Tue, Jan 31st 2012 ] - Market Wire
Inovio Pharmaceuticals Moves Closer to quot;&# .. luenza Vaccine by Demonstrating Protective Immune
[ Tue, Jan 31st 2012 ] - Market Wire
Inovio Pharmaceuticals Moves Closer to "Universal .. trating Protective Immune Responses Against Multi
Mon, January 30, 2012
[ Mon, Jan 30th 2012 ] - Market Wire
Helix BioPharma Corp. Updates Shareholders on Results From Annual General Meeting
[ Mon, Jan 30th 2012 ] - Market Wire
FDA approves Jentaduetoa" (linagliptin/metformin .. e treatment of adult patients with type 2 diabete
[ Mon, Jan 30th 2012 ] - Market Wire
Molina Healthcare Recognized for Exemplary Workplace Practices
[ Mon, Jan 30th 2012 ] - Market Wire
Data Presented at STS Reinforce Positive Clinical .. nic CoreValve System Using Direct Aortic Approach
[ Mon, Jan 30th 2012 ] - Market Wire
Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors
[ Mon, Jan 30th 2012 ] - Market Wire
ThermoGenesis Announces Management Transition in Conjunction With Tactical Realignment of Company
[ Mon, Jan 30th 2012 ] - Market Wire
DURECT Receives Back European Product Rights to POSIDURa"
[ Mon, Jan 30th 2012 ] - Market Wire
Amylin Pharmaceuticals to Webcast 2011 Year-End Financial Results
[ Mon, Jan 30th 2012 ] - Market Wire
Substantial New Transcatheter Patient Data Presented at STS
[ Mon, Jan 30th 2012 ] - Market Wire
Fibrocell Science, Inc. Announces Recognition for .. 2012 Cell & Gene Therapy Forum, Washington, D.C.
[ Mon, Jan 30th 2012 ] - Market Wire
Health Management Associates Appoints Paul Hurst as Senior Vice President of Government Relations
[ Mon, Jan 30th 2012 ] - Market Wire
Hospira Names Richard Davies Chief Commercial Officer
[ Mon, Jan 30th 2012 ] - Market Wire
Neurocrine Biosciences, Inc. Announces Exercise i .. nderwriters' Option to Purchase Additional Shares
[ Mon, Jan 30th 2012 ] - Market Wire
Genomic Health to Announce Fourth Quarter and Yea .. and Host Conference Call on Monday, February 6, 2
[ Mon, Jan 30th 2012 ] - Market Wire
Orthofix International to Participate in the Canaccord Genuity Musculoskeletal Conference

Orthofix International to Participate in the Canaccord Genuity Musculoskeletal Conference


Published on 2012-01-30 13:10:43 - Market Wire
  Print publication without navigation


LEWISVILLE, Texas--([ ])--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it will participate in the Canaccord Genuity Musculoskeletal Conference on Tuesday, February 7th at 1:40 PM Pacific Time at the Parc 55 Wyndham Hotel in San Francisco, CA.

A live audio webcast will be available on the Companyas website at [ www.orthofix.com ] by clicking on the Investors tab and then clicking the link on the Events & Presentations page.

About Orthofix:

Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofixas products are widely distributed around the world to orthopedic surgeons and patients via Orthofixas sales representatives and its subsidiaries, including BREG, Inc., and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, Texas Scottish Rite Hospital for Children, and the Cleveland Clinical Foundation. For more information about Orthofix, please visit [ www.orthofix.com ].

Contributing Sources